To further explore the oncogenic role of TRIM8 in hepatoma cells, TRIM8 gene knockout (TRIM8-KO) HepG2 cells were constructed using CRISPR-Cas9 technology (Supplementary Fig. S2G). This evidence concerns the gene TRIM8 and hepatocellular carcinoma.